PCP4/PEP19 and HER2 Are Novel Prognostic Markers in Mucoepidermoid Carcinoma of the Salivary Gland

SIMPLE SUMMARY: Mucoepidermoid carcinoma (MEC) is the most common malignancy of all salivary neoplasms, and no effective treatment strategy for MEC has been established other than resection. In this study, we showed that Purkinje cell protein (PCP) 4/peptide (PEP) 19 and human epidermal growth facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimura, Takuya, Higashi, Shotaro, Yamada, Sohsuke, Noguchi, Hirotsugu, Nomoto, Mitsuharu, Suzuki, Hajime, Ishida, Takayuki, Takayama, Hirotaka, Hirano, Yuka, Yamashita, Masaru, Tanimoto, Akihide, Nakamura, Norifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750196/
https://www.ncbi.nlm.nih.gov/pubmed/35008217
http://dx.doi.org/10.3390/cancers14010054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750196/
https://www.ncbi.nlm.nih.gov/pubmed/35008217
http://dx.doi.org/10.3390/cancers14010054

Ejemplares similares